About Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality high-grade full spectrum cannabinoid oil on the market. There are positive results in studies on breast cancer and immune cells through the University of Central Oklahoma, in addition to studies through DV Biologics that prove the Company’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive result case studies through key health organizations. ETST formulates, markets and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD on the market.
October 03, 2018 08:00 ET | Source: Earth Science Tech, Inc. Earth Science Tech, Inc.
“The results obtained from TransBiotech will help us understand the mechanism of action of CBD and will open the doors for the research needed to develop revolutionary CDB-based pharmaceutical drugs,” says ETST president and CEO Nickolas Tabraue. “We will provide more details on the progress of these formulas in the near future, as well as an update on the first CBD-based pharmaceutical product we are developing with Bionatus for the treatment of asthma, as announced last year.”
Earth Science Pharmaceutical, Inc.
Earth Science Pharmaceutical (“ESP”) is a wholly owned subsidiary of Earth Science Tech), committed to the development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. ESP’s CEO and chief science officer, Dr. Michel Aubé, is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. ESP is working to develop and bring to market medical devices and vaccines that meet the specific needs of women. To learn more please visit: www.EarthSciencePharmaceutical.com
ETST plans to share further updates on its CBD patent formulas and CBD-based pharmaceuticals as each progress.
ETST CEO and Chief Science Officer Dr. Michel Aubé is ecstatic about the changes. “In 2018, we have a much deeper understanding of cannabinoids, cannabinoid-receptors, and the endocannabinoid system than we did decades ago when CBD was classified as a schedule 1 drug. We are pleased to see that the DEA has shifted its stance amid conclusive evidence that CBD is not addictive but has both anti-psychotic properties and the opposite effect of THC.”
Cannabis Therapeutics, Inc.
Cannabis Therapeutics (“CTI”) is a wholly owned subsidiary of Earth Science TechTich i poised to take a leadership role in the development of new, leading-edge cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds three provisional application patents for a CBD product that is focused on developing treatments for breast and ovarian cancers, as well as two generic CBD based pharmaceutical drugs. To learn more please visit: www.CannabisThera.com
We like how Earth Science Tech makes it a point to focus on the science behind CBD, and they offer a lot of valuable information on their website about phytocannabinoids and the endocannabinoid system. However, their product descriptions aren’t as helpful as many customers would like, and their unique CBD concentrations may be difficult to understand for some consumers, especially those that are newer to the market.
If you want to give your pet CBD, this oil is a safe option since it uses MCT (coconut) oil as a carrier oil.
Earth Science Tech, also referred to as ETST, is a science based biotechnology company that performs research alongside the University of Central Oklahoma, DV Biologics laboratory, and other organizations in an effort to discover the effects of CBD as a dietary supplement. This brand offers full-spectrum CBD products, which have been extracted using super-critical CO2 fluid extraction, which they believe helps maintain the highest quality of cannabinoid composition for maximum therapeutic benefit.
Reliva CBD Review
Three different flavor options to choose from, and features a wide range of cannabinoids for added benefit.
© 2021 Remedy Review. All rights reserved.
328.5mg, 657mg, 1314mg, or 2628mg
Earth Science Tech originally planned on using American grown hemp for their CBD products, but instead they opted for a reliable, high quality source from European family-owned farms to supply them with industrial hemp.